openPR Logo
Press release

Insulin Pump Sensor Market Share Driven by Rising Diabetes Prevalence and Advancements in Continuous Glucose Monitoring Technologies | Valuates Reports

04-21-2026 03:08 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Valuates Reports

Insulin Pump Sensor Market
The global market for Insulin Pump Sensor was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-11C1444/Global_Insulin_Pump_Sensor_Market_Insights_Forecast_to_2028

The Insulin Pump Sensor Market is experiencing strong market growth driven by the increasing global prevalence of diabetes and the growing demand for advanced glucose monitoring solutions. Insulin pump sensors play a crucial role in continuous glucose monitoring systems, enabling real-time tracking of blood glucose levels and improving diabetes management. One of the key market trends shaping the market size is the shift toward personalized and connected healthcare, where patients increasingly rely on wearable medical devices for continuous monitoring and automated insulin delivery. This trend is significantly boosting market share, as patients and healthcare providers seek more accurate, convenient, and reliable solutions. Additionally, technological advancements in sensor accuracy, miniaturization, and wireless connectivity are enhancing device performance and user experience. The integration of insulin pumps with mobile applications and digital health platforms is further supporting market growth. Increasing awareness of diabetes management and the importance of maintaining optimal glucose levels is also contributing to the expansion of the market. As healthcare systems continue to emphasize patient-centric care, the overall market forecast remains highly positive.

From a type segmentation perspective, invasive glucose sensors hold the largest market share due to their established use in continuous glucose monitoring systems and their ability to provide highly accurate real-time data. These sensors are widely adopted in both clinical and homecare settings, contributing significantly to the overall market size. Their reliability and integration with insulin pump systems make them a preferred choice among patients and healthcare providers. Meanwhile, non-invasive glucose sensors are witnessing the fastest market growth, driven by the increasing demand for painless and convenient monitoring solutions. These sensors eliminate the need for skin penetration, improving patient comfort and compliance. Continuous innovation in non-invasive technologies is shaping market trends and accelerating adoption, as companies focus on improving accuracy and usability.

In terms of application segmentation, homecare accounts for the largest market share, driven by the growing preference for self-management of diabetes and the increasing adoption of wearable monitoring devices. Insulin pump sensors enable patients to monitor glucose levels continuously without frequent hospital visits, contributing significantly to the overall market size. Hospitals and clinics are witnessing steady market growth, supported by the need for advanced monitoring systems in managing complex diabetes cases and ensuring accurate treatment. Diagnostic centers also represent a significant application area, where sensors are used for testing and monitoring purposes. Other applications contribute to the market share by supporting diverse healthcare needs. As the focus on remote patient monitoring and digital health continues to grow, the application segment is expected to play a key role in shaping the future market forecast.

The competitive landscape of the Insulin Pump Sensor Market is characterized by the presence of several leading medical device and healthcare companies focusing on innovation and integrated diabetes care solutions. Companies such as Dexcom, Medtronic, and Insulet hold the largest market share due to their strong product portfolios, advanced technologies, and widespread adoption of their continuous glucose monitoring systems. These companies have established themselves as leaders by delivering reliable and user-friendly solutions that integrate seamlessly with insulin pumps. Dexcom demonstrates strong market growth through its focus on continuous innovation and real-time glucose monitoring technologies, while Medtronic leverages its extensive experience in diabetes care to expand its market share. Insulet continues to strengthen its position through its tubeless insulin pump systems and integrated sensor technologies. Other companies such as Eli Lilly, BD, and Bigfoot Biomedical contribute significantly to the market through their focus on developing next-generation diabetes management solutions. Emerging players including GlySens, GluSense, and Gluco-Chaser are actively expanding their market share through innovative sensor technologies and research initiatives. CCS Medical plays an important role in distribution and patient support services, while Boston Scientific is involved in broader medical device innovation. The competitive environment is driven by technological advancement, product accuracy, and the ability to improve patient outcomes.

Regionally, North America dominates the Insulin Pump Sensor Market in terms of market share, driven by advanced healthcare infrastructure, high adoption of digital health technologies, and strong awareness of diabetes management. The region's market size is supported by the presence of leading companies and favorable reimbursement policies. Europe also represents a significant market, characterized by increasing adoption of continuous glucose monitoring systems and supportive healthcare frameworks. The Asia-Pacific region is emerging as the fastest-growing market, driven by rising diabetes prevalence, improving healthcare infrastructure, and increasing awareness in countries such as China, Japan, South Korea, and Taiwan. Southeast Asia is witnessing notable market growth, supported by expanding healthcare access and growing adoption of advanced medical technologies in countries such as India. Latin America is experiencing steady market growth, driven by improving healthcare services and increasing demand for diabetes management solutions in countries such as Mexico and Brazil. The overall market forecast indicates sustained market growth across all regions, driven by increasing demand for continuous glucose monitoring, continuous advancements in sensor technologies, and the global shift toward personalized and connected healthcare solutions.

Segment by Type

• Invasive Glucose Sensor
• Non-Invasive Glucose Sensor

Segment by Application

• Homecare
• Hospitals and Clinics
• Diagnostic Center

By Company

Animas, BD, Bigfoot Biomedical, Boston Scientific, CCS Medical, Dexcom, Eli Lilly, Gluco-Chaser, GluSense, GlySens, Insulet, Medtronic

View full report
https://reports.valuates.com/market-reports/QYRE-Auto-11C1444/global-insulin-pump-sensor

Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066,

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Insulin Pump Sensor Market Share Driven by Rising Diabetes Prevalence and Advancements in Continuous Glucose Monitoring Technologies | Valuates Reports here

News-ID: 4482348 • Views:

More Releases from Valuates Reports

1064nm DPSS Laser Market Share Driven by Precision Manufacturing Demand and Advancements in Laser Technology | Valuates Reports
1064nm DPSS Laser Market Share Driven by Precision Manufacturing Demand and Adva …
1064nm DPSS Laser Market The global market for 1064nm DPSS Laser was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period. View sample report https://reports.valuates.com/request/sample/QYRE-Auto-33V14690/Global_1064nm_DPSS_Laser_Market_Research_Report_2023 The 1064nm DPSS Laser Market is experiencing significant market growth as industries increasingly adopt high-precision laser technologies for a wide range of applications. Diode-pumped solid-state lasers operating at
Moulded Case Circuit Breaker (MCCB) Market Share Driven by Electrification Expansion and Rising Demand for Smart Power Protection Solutions | Valuates Reports
Moulded Case Circuit Breaker (MCCB) Market Share Driven by Electrification Expan …
Moulded Case Circuit Breaker (MCCB) Market Size The global Moulded Case Circuit Breaker (MCCB) market was valued at US$ 4353 million in 2025 and is anticipated to reach US$ 6340 million by 2032, at a CAGR of 5.6% from 2026 to 2032. View sample report https://reports.valuates.com/request/sample/QYRE-Auto-11170/Global_Moulded_Case_Circuit_Breaker_MCCB_Market_Insights_and_Forecast_to_2028 The Moulded Case Circuit Breaker (MCCB) Market is experiencing steady market growth as global demand for reliable electrical protection systems continues to expand across industrial, commercial, and infrastructure
Degarelix Acetate API Market Share Driven by Rising Prostate Cancer Treatment Demand and Expanding Peptide Manufacturing Capabilities | Valuates Reports
Degarelix Acetate API Market Share Driven by Rising Prostate Cancer Treatment De …
Degarelix Acetate API Market The global market for Degarelix Acetate API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period. View sample report https://reports.valuates.com/request/sample/QYRE-Auto-31C11265/Global_Degarelix_Acetate_API_Market_Research_Report_2022 The Degarelix Acetate API Market is gaining traction as the global healthcare industry continues to focus on effective treatments for hormone-sensitive cancers, particularly prostate cancer. Degarelix acetate, a
Modified Atmospheric Packaging Analysers Market Share Driven by Food Safety Regulations and Rising Demand for Shelf-Life Optimization | Valuates Reports
Modified Atmospheric Packaging Analysers Market Share Driven by Food Safety Regu …
Modified Atmospheric Packaging Analysers Market Modified Atmospheric Packaging Analyzers are instruments used to measure and analyze the composition and quality of gases within modified atmosphere packaging (MAP) systems. MAP is a packaging technique that involves altering the atmosphere surrounding a product to extend its shelf life and maintain its quality. The global Modified Atmospheric Packaging Analysers market was valued at US$ million in 2023 and is anticipated to reach US$ million by

All 5 Releases


More Releases for Insulin

Insulin Delivery System Advancement Drives the Global Insulin Path Pumps Market
Inkwood Research expects the Global Insulin Patch Pumps Market to surge with a 10.63% CAGR by 2032, and is set to generate $2760.98 million during the forecast period 2023-2032. Browse 50 market data Tables and 47 Figures spread over 173 Pages, along with an in-depth analysis of the Global Insulin Patch Pumps Market by Type, Delivery Mode, Disease Indication, Distribution Channel, & by Geography. Refer to the Report Summary Here: https://inkwoodresearch.com/reports/insulin-patch-pumps-market/#report-summary?utm_source=PaidPRNew&utm_medium=OpenPR&utm_campaign=InkwoodPR This
Advancing Insulin Delivery Systems boost the Global Insulin Path Pumps Market
Inkwood Research expects the Global Insulin Patch Pumps Market to surge with a 10.63% CAGR by 2032, and is set to generate $2760.98 million during the forecast period 2023-2032. Browse 50 market data Tables and 47 Figures spread over 173 Pages, along with an in-depth analysis of the Global Insulin Patch Pumps Market by Type, Delivery Mode, Disease Indication, Distribution Channel, & by Geography. Refer to the Report Summary Here: https://inkwoodresearch.com/reports/insulin-patch-pumps-market/#report-summary This insightful
Advancing Insulin Delivery Systems boost the Global Insulin Path Pumps Market
Inkwood Research expects the Global Insulin Patch Pumps Market to surge with a 10.63% CAGR by 2032, and is set to generate $2760.98 million during the forecast period 2023-2032. Browse 50 market data Tables and 47 Figures spread over 173 Pages, along with an in-depth analysis of the Global Insulin Patch Pumps Market by Type, Delivery Mode, Disease Indication, Distribution Channel, & by Geography. Refer to the Report Summary Here: https://inkwoodresearch.com/reports/insulin-patch-pumps-market/#report-summary This insightful
Insulin Pumps Market Share, Trends and Growth Analysis By Type (Traditional Insu …
Insulin Pumps Market is expected to register a CAGR of 15.5% and acquire the market value of USD 11.5 Billion by 2028 during forecast period 2023-2032. Insulin pumps are discreet, electronic medical devices that can be tucked beneath clothing or fastened to a belt. In order to regulate the rise in blood glucose levels, the pump is used to deliver controlled quantities of insulin within the body at regular intervals
Insulin Patch Pumps Market Report 2018: Segmentation by Insulin Type (Bolus Insu …
Global Insulin Patch Pumps market research report provides company profile for Roche Holding AG, Cellnovo Group SA, Spring Health Solution Ltd., Debiotech, CeQur SA, Valeritas, Becton Dickenson & Company, Insulet Corporation, Johnson & Johnson, Medtrum Technologies Inc. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue,
Insulin pump Market Explore Future Growth 2018-2026 by Global Type-Traditional i …
Insulin pump is a portable device attached to the body that continuously delivers preset amounts of short or rapid acting insulin in the body to control diabetes. Insulin therapy is required in type 1 diabetes and sometime in type 2 diabetes. It serves as an effective alternative to insulin injections. Furthermore, insulin pump delivers the insulin according to the need of body as basal rate, where small amount of insulin